To see the effects of ethambutol, which is a drug for treatment of tuberculosis, on the ocular structure and function of patients
Not Applicable
- Conditions
- Health Condition 1: A199- Miliary tuberculosis, unspecifiedHealth Condition 2: A159- Respiratory tuberculosis unspecifiedHealth Condition 3: A179- Tuberculosis of nervous system, unspecifiedHealth Condition 4: A188- Tuberculosis of other specified organs
- Registration Number
- CTRI/2024/06/068652
- Lead Sponsor
- Department of Ophthalmology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Newly diagnosed patients of Tuberculosis (Clinically or Microbiologically proven/ Sputum smear positive) from the age of 18 years and above – receiving daily regimen of ATT (2HRZE+4HRE regimen)
Exclusion Criteria
Category II, III, IV Tuberculosis patients
Moderate-to-severe Glaucoma
Hereditary Optic Neuropathy
Ischemic Optic Neuropathy
Traumatic Optic Neuropathy
HIV patients on Anti-Retroviral therapy
Ocular TB
Tubercular meningitis
Any systemic medical condition (e.g., cognitive impairment, Parkinson’s disease, Alzheimer’s disease, Multiple sclerosis and any other neurological or musculoskeletal disease) which might preclude the patient from giving reliable results on investigations
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method